About AOD-9604 Compound.

What this site is

AOD-9604 Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on AOD-9604 — the C-terminal lipolytic fragment of human growth hormone, residues 176-191. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "compound" in the name is a research-literature framing — a position this publisher occupies relative to the studies, not a claim about services. There is no dispensary behind this page and no consultation on offer.

How we read the record

We lead with what was measured and attribute it to its source. Where the data is animal data, we say so. Where the human result is null — as it is for AOD-9604's pivotal obesity trial — we say that plainly rather than burying it. We report doses only as studied figures by species and route, never as guidance for a person.

We do not overstate the marketing-favourite "fat-burning peptide" framing: the foundational characterisation of this fragment is antilipogenic (suppressing new fat synthesis), and the human weight-loss evidence is negative. Our job is to keep that distinction visible.

What we will not do

We will not recommend a dose, a route, or a protocol. We will not claim a benefit the trials did not show. We will not name drug brands or sell anything. We will not invent citations — if a claim is not in the published literature, it is not on this site. Corrections to anything we have summarised are welcome.